Morningside Venture Investments Ltd Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

Morningside Venture Investments LTD is > 10% Shareholder of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 5 Million shares of AMLX, which is worth approximately $23.8 Million. The most recent transaction as insider was on Aug 15, 2023, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5M

0% 3M change

0% 12M change

Total Value Held $23.8 Million

Morningside Venture Investments Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 15 2023	SELL Bona fide gift	-	2,000,000 Reduced 28.58%	4,997,302 Common Stock
Mar 29 2023	SELL Open market or private sale	$884,511 $30.45 p/Share	29,048 Reduced 0.41%	6,997,302 Common Stock
Mar 28 2023	SELL Open market or private sale	$3,037,000 $30.37 p/Share	100,000 Reduced 1.4%	7,026,350 Common Stock
Mar 27 2023	SELL Open market or private sale	$1,861,230 $30.53 p/Share	60,964 Reduced 0.85%	7,126,350 Common Stock
Mar 21 2023	SELL Open market or private sale	$2,025,894 $31.93 p/Share	63,448 Reduced 0.88%	7,187,314 Common Stock
Mar 16 2023	SELL Open market or private sale	$296,921 $32.55 p/Share	9,122 Reduced 0.13%	7,250,762 Common Stock
Mar 15 2023	SELL Open market or private sale	$5,010,000 $33.4 p/Share	150,000 Reduced 2.02%	7,259,884 Common Stock
Mar 14 2023	SELL Open market or private sale	$2,442,461 $34.54 p/Share	70,714 Reduced 0.95%	7,409,884 Common Stock
Mar 02 2023	SELL Open market or private sale	$1,687,500 $33.75 p/Share	50,000 Reduced 0.66%	7,480,598 Common Stock
Feb 23 2023	SELL Open market or private sale	$1,795,000 $35.9 p/Share	50,000 Reduced 0.66%	7,580,598 Common Stock
Feb 22 2023	SELL Open market or private sale	$1,751,000 $35.02 p/Share	50,000 Reduced 0.66%	7,530,598 Common Stock
Feb 22 2023	SELL Open market or private sale	$1,806,500 $36.13 p/Share	50,000 Reduced 0.65%	7,630,598 Common Stock
Jan 11 2022	BUY Conversion of derivative security	-	10,415,650 Added 50.0%	10,415,650 Common Stock
Jan 11 2022	BUY Open market or private purchase	$5,000,002 $19.0 p/Share	263,158 Added 2.41%	10,678,808 Common Stock

Also insider at

APLS

Apellis Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

GRNA

GreenLight Biosciences Holdings, PBC Healthcare

KZR

Kezar Life Sciences, Inc. Healthcare

MVI